Suppr超能文献

使用海藻酸钙凝胶的吲哚美辛控释制剂

Controlled-release preparation of indomethacin using calcium alginate gel.

作者信息

Shiraishi S, Imai T, Otagiri M

机构信息

Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

出版信息

Biol Pharm Bull. 1993 Nov;16(11):1164-8. doi: 10.1248/bpb.16.1164.

Abstract

Alginate gel beads containing indomethacin (IMC) were prepared using a gelation of alginate with calcium cation. Though IMC was not released from the beads at pH 1.2 because of its extremely low solubility in aqueous media, it was released according to the swelling of alginate gel at pH 6.8. The release of IMC from the beads decreased with the decreasing ratio of mannuronic acid (M) to guluronic acid (G) in alginate, and with the larger molecular weight of alginate. The maximum concentration and the area under the time curve of plasma concentration of IMC after oral administration of alginate gel beads to beagle dogs were lower than those of IMC powder. The absorption rate of IMC was lower and more prolonged after administration of beads containing IMC than IMC powder alone. The high plasma concentration of IMC was maintained because absorption continued for a longer period when the bead consisting of the alginate with 0.65 M-block/G-block ratio and 66000 molecular weight was administered. The availability of alginate gel beads of IMC was further demonstrated by oral administration to human volunteers. A serum concentration which was comparable to maximum serum concentration was maintained from 2 to 6 h after administration, while an effective serum concentration was maintained even 12 h after administration of the beads. These data suggest that alginate is useful for a controlled-release formulation of IMC.

摘要

采用海藻酸钠与钙阳离子凝胶化的方法制备了含吲哚美辛(IMC)的海藻酸钠凝胶珠。尽管由于IMC在水性介质中的溶解度极低,其在pH 1.2时不会从凝胶珠中释放出来,但在pH 6.8时,它会随着海藻酸钠凝胶的溶胀而释放。IMC从凝胶珠中的释放量随着海藻酸钠中甘露糖醛酸(M)与古洛糖醛酸(G)比例的降低以及海藻酸钠分子量的增大而减少。给比格犬口服海藻酸钠凝胶珠后,IMC的血浆浓度最大浓度和时间曲线下面积低于IMC粉末。与单独服用IMC粉末相比,服用含IMC的凝胶珠后,IMC的吸收速率更低且持续时间更长。当给予由M嵌段/G嵌段比例为0.65且分子量为66000的海藻酸钠组成的凝胶珠时,由于吸收持续更长时间,IMC的高血浆浓度得以维持。对人类志愿者进行口服给药进一步证明了IMC海藻酸钠凝胶珠的有效性。给药后2至6小时维持了与最大血清浓度相当的血清浓度,而给药后12小时仍维持了有效血清浓度。这些数据表明海藻酸钠可用于IMC的控释制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验